February PMI index drops to 53.4%

Industrial activity in February slipped again as the Purchases Managers Index (PMI) dropped percentage point to 53.4% after a 1.5-point drop in January research company Dun & Bradstreet Israel said Thursday.

By SHARON WROBEL
March 15, 2007 07:05

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Industrial activity in February slipped again as the Purchases Managers Index (PMI) dropped percentage point to 53.4% after a 1.5-point drop in January research company Dun & Bradstreet Israel said Thursday. Still, PMI values above 50% reflect growth, and D&B economists said they expected productivity to continue to grow and the economy to expand throughout the next couple of months, given that the central components in the index expanded during February. The index's employment element fell by a moderate 2.6 percentage points to 55.9%, after dropping 7.8 points in the previous month. The domestic demand component of the index rose 1.7 percentage points to 53.6%.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS